logo
Plus   Neg
Share
Email

Astellas Pharma: Roxadustat Approved In Japan For Adults With Anemia Of CKD Not On Dialysis

Astellas Pharma Inc. (ALPMY) and FibroGen, Inc. (FGEN) announced that Japan's Ministry of Health, Labour and Welfare approved EVRENZO (roxadustat) for the treatment of anemia of chronic kidney disease in adult patients not on dialysis. This approval triggers a milestone payment of $15 million by Astellas to FibroGen.

The approval is based on results obtained from three clinical studies in more than 500 Japanese patients with anemia of CKD not on dialysis. The phase 3 conversion study versus active comparator, darbepoetin alfa, met the primary efficacy endpoint. Roxadustat was generally well tolerated, and the safety profile was comparable with that of darbepoetin alfa.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Polaris Industries Inc. recalled about 15,800 units of Off-Road and Utility Vehicles in North America for possible crash hazard, according to a statement issued by the U.S. Consumer Product Safety Commission. There were also an additional 711 units sold in Canada. AstraZeneca's efforts to supply Covid-19 vaccine doses from its Italian unit to Australia has been blocked by the European Union and the Italian Government, citing Australia being non-vulnerable region and delays in domestic supply, among others. Italy's proposal to deny AstraZeneca's request for authorization to export COVID-19 vaccines was subsequently approved by the European Commission. Chipotle Mexican Grill, Inc. is teaming with e.l.f. Cosmetics to launch a limited edition beauty collection on March 10, aiming to support plant-based lifestyles and responsibly-sourced products. The e.l.f. x Chipotle makeup collection will comprise cruelty-free and vegan products inspired by Chipotle's responsibly-raised food.
Follow RTT